{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:17:15Z","timestamp":1778156235373,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Data driven new lifestyle intervention model mining and prevention and control strategy research for type 2 diabetes","award":["2024ZD0531800"],"award-info":[{"award-number":["2024ZD0531800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"DOI":"10.1186\/s13321-026-01158-w","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:55:45Z","timestamp":1770256545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cosynllm: predicting drug combination synergy with LLM-generated descriptions"],"prefix":"10.1186","volume":"18","author":[{"given":"Suwan","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"1158_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01435-2","volume":"8","author":"J Chen","year":"2025","unstructured":"Chen J, Lin A, Jiang A, Luo P, Li Y, Zhang Y, Zhang X (2025) Computational frameworks transform antagonism to synergy in optimizing combination therapies. Npj Digit Med 8(1):44. https:\/\/doi.org\/10.1038\/s41746-025-01435-2","journal-title":"Npj Digit Med"},{"issue":"5","key":"1158_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad285","volume":"24","author":"J Gu","year":"2023","unstructured":"Gu J, Bang D, Yi J, Lee S, Kim DK, Kim S (2023) A model-agnostic framework to enhance knowledge graph-based drug combination prediction with drug-drug interaction data and supervised contrastive learning. Brief Bioinform 24(5):285. https:\/\/doi.org\/10.1093\/bib\/bbad285","journal-title":"Brief Bioinform"},{"issue":"1","key":"1158_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13321-024-00859-4","volume":"16","author":"R AlJarf","year":"2024","unstructured":"AlJarf R, Rodrigues CHM, Myung Y, Pires DEV, Ascher DB (2024) piscesCSM: prediction of anticancer synergistic drug combinations. J Cheminform 16(1):81. https:\/\/doi.org\/10.1186\/s13321-024-00859-4","journal-title":"J Cheminform"},{"issue":"7","key":"1158_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100411","volume":"2","author":"L Wu","year":"2023","unstructured":"Wu L, Gao J, Zhang Y, Sui B, Wen Y, Wu Q, Liu K, He S, Bo X (2023) A hybrid deep forest-based method for predicting synergistic drug combinations. Cell Rep Methods 2(7):100293. https:\/\/doi.org\/10.1016\/j.crmeth.2023.100411","journal-title":"Cell Rep Methods"},{"key":"1158_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sbi.2024.102827","volume":"86","author":"F Abbasi","year":"2024","unstructured":"Abbasi F, Rousu J (2024) New methods for drug synergy prediction: a mini-review. Curr Opin Struct Biol 86:1\u20139. https:\/\/doi.org\/10.1016\/j.sbi.2024.102827","journal-title":"Curr Opin Struct Biol"},{"key":"1158_CR6","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A de Gramont","year":"2000","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938\u20132947","journal-title":"J Clin Oncol"},{"issue":"1","key":"1158_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01024-9","volume":"7","author":"T Li","year":"2024","unstructured":"Li T, Shetty S, Kamath A, Jaiswal A, Jiang X, Ding Y, Kim Y (2024) CancerGPT for few shot drug pair synergy prediction using large pretrained language models. npj Digit Med 7(1):40. https:\/\/doi.org\/10.1038\/s41746-024-01024-9","journal-title":"npj Digit Med"},{"issue":"16","key":"1158_CR8","doi-asserted-by":"publisher","first-page":"6421","DOI":"10.1021\/acs.jcim.4c01101","volume":"64","author":"A Mehmood","year":"2024","unstructured":"Mehmood A, Kaushik AC, Wei D-Q (2024) DDSBC: a stacking ensemble classifier-based approach for breast cancer drug-pair cell synergy prediction. J Chem Inf Model 64(16):6421\u20136431. https:\/\/doi.org\/10.1021\/acs.jcim.4c01101","journal-title":"J Chem Inf Model"},{"issue":"12","key":"1158_CR9","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1093\/bioinformatics\/btv080","volume":"31","author":"P Li","year":"2015","unstructured":"Li P, Huang C, Fu Y, Wang J, Wu Z, Ru J, Zheng C, Guo Z, Chen X, Zhou W, Zhang W, Li Y, Chen J, Lu A, Wang Y (2015) Large-scale exploration and analysis of drug combinations. Bioinformatics 31(12):2007\u20132016. https:\/\/doi.org\/10.1093\/bioinformatics\/btv080","journal-title":"Bioinformatics"},{"issue":"7","key":"1158_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068598","volume":"8","author":"P Gerlee","year":"2013","unstructured":"Gerlee P, Schmidt L, Monsefi N, Kling T, Jornsten R, Nelander S (2013) Searching for synergies: matrix algebraic approaches for efficient pair screening. PLoS One 8(7):68598. https:\/\/doi.org\/10.1371\/journal.pone.0068598","journal-title":"PLoS One"},{"issue":"12","key":"1158_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/bioinformatics\/btu278","volume":"30","author":"L Huang","year":"2014","unstructured":"Huang L, Li F, Sheng J, Xia X, Ma J, Zhan M, Wong STC (2014) DrugComboRanker: drug combination discovery based on target network analysis. Bioinformatics 30(12):228\u2013236. https:\/\/doi.org\/10.1093\/bioinformatics\/btu278","journal-title":"Bioinformatics"},{"issue":"7","key":"1158_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2025.100892","volume":"5","author":"H Xu","year":"2025","unstructured":"Xu H, Lin J, Woicik A, Liu Z, Ma J, Zhang S, Poon H, Wang L, Wang S (2025) Pisces: a multi-modal data augmentation approach for drug combination synergy prediction. Cell Genom 5(7):100892. https:\/\/doi.org\/10.1016\/j.xgen.2025.100892","journal-title":"Cell Genom"},{"issue":"9","key":"1158_CR13","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","volume":"34","author":"K Preuer","year":"2017","unstructured":"Preuer K, Lewis RPI, Hochreiter S, Bender A, Bulusu KC, Klambauer G (2017) DeepSynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics 34(9):1538\u20131546. https:\/\/doi.org\/10.1093\/bioinformatics\/btx806","journal-title":"Bioinformatics"},{"key":"1158_CR14","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2025.3561887","author":"B Sun","year":"2025","unstructured":"Sun B, Du H, Hou S, Hu Q, Pang X, Wei D, Wang X (2025) Enhancing drug synergy combination: integrating graph transformers and BiLSTM for accurate drug synergy prediction. IEEE J Biomed Health Inform. https:\/\/doi.org\/10.1109\/JBHI.2025.3561887","journal-title":"IEEE J Biomed Health Inform"},{"issue":"2","key":"1158_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae015","volume":"25","author":"Y Guo","year":"2024","unstructured":"Guo Y, Hu H, Chen W, Yin H, Wu J, Hsieh C-Y, He Q, Cao J (2024) SynergyX: a multi-modality mutual attention network for interpretable drug synergy prediction. Brief Bioinform 25(2):015. https:\/\/doi.org\/10.1093\/bib\/bbae015","journal-title":"Brief Bioinform"},{"key":"1158_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-0716-0849-4_12","volume":"2194","author":"T Zhang","year":"2021","unstructured":"Zhang T, Zhang L, Payne PRO, Li F (2021) Synergistic drug combination prediction by integrating multiomics data in deep learning models. Methods Mol Biol Clifton NJ 2194:223\u2013238. https:\/\/doi.org\/10.1007\/978-1-0716-0849-4_12","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"4","key":"1158_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad177","volume":"39","author":"MR El Khili","year":"2023","unstructured":"El Khili MR, Memon SA, Emad A (2023) MARSY: a multitask deep-learning framework for prediction of drug combination synergy scores. Bioinformatics 39(4):177. https:\/\/doi.org\/10.1093\/bioinformatics\/btad177","journal-title":"Bioinformatics"},{"issue":"2","key":"1158_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008653","volume":"17","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xie L (2021) TranSynergy: mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations. PLoS Comput Biol 17(2):1008653. https:\/\/doi.org\/10.1371\/journal.pcbi.1008653","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"1158_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab420","volume":"23","author":"J Wang","year":"2022","unstructured":"Wang J, Liu X, Shen S, Deng L, Liu H (2022) DeepDDS: deep graph neural network with attention mechanism to predict synergistic drug combinations. Brief Bioinform 23(1):390. https:\/\/doi.org\/10.1093\/bib\/bbab420","journal-title":"Brief Bioinform"},{"issue":"3","key":"1158_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010951","volume":"19","author":"P Zhang","year":"2023","unstructured":"Zhang P, Tu S (2023) MGAE-DC: predicting the synergistic effects of drug combinations through multi-channel graph autoencoders. PLoS Comput Biol 19(3):1010951. https:\/\/doi.org\/10.1371\/journal.pcbi.1010951","journal-title":"PLoS Comput Biol"},{"key":"1158_CR21","doi-asserted-by":"publisher","DOI":"10.1109\/JBHI.2024.3511657","author":"J Yu","year":"2024","unstructured":"Yu J, Chen N, Cao L, Gao M, Liu D, Wang F, Lin Q, Li X, Wong K-C (2024) Synergizing anti-cancer drug combinations with dual-view hypergraph representation fusion. IEEE J Biomed Health Inform. https:\/\/doi.org\/10.1109\/JBHI.2024.3511657","journal-title":"IEEE J Biomed Health Inform"},{"issue":"9","key":"1158_CR22","doi-asserted-by":"publisher","first-page":"17086","DOI":"10.1109\/TNNLS.2025.3553385","volume":"36","author":"M Chen","year":"2025","unstructured":"Chen M, Zhang M, Yan G, Wang G, Qu C (2025) MRHGNN: enhanced multimodal relational hypergraph neural network for synergistic drug combination forecasting. IEEE Trans Neural Netw Learn Syst 36(9):17086\u201317098. https:\/\/doi.org\/10.1109\/TNNLS.2025.3553385","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"1158_CR23","doi-asserted-by":"crossref","unstructured":"Zheng Y, Koh HY, Yang M, Li L, May LT, Webb GI, Pan S, Church G (2024) Large language models in drug discovery and development: from disease mechanisms to clinical trials","DOI":"10.1016\/j.patter.2025.101346"},{"issue":"1","key":"1158_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59822-y","volume":"16","author":"T Liu","year":"2025","unstructured":"Liu T, Chu T, Luo X, Zhao H (2025) Building a unified model for drug synergy analysis powered by large language models. Nat Commun 16(1):4537. https:\/\/doi.org\/10.1038\/s41467-025-59822-y","journal-title":"Nat Commun"},{"key":"1158_CR25","doi-asserted-by":"publisher","DOI":"10.1101\/2025.07.09.657250","author":"T Li","year":"2025","unstructured":"Li T, Fang Z, Zhang X, Tang K, Chen H, Jiang Z, Zhao T, Xu R, Cheng F, Li X, Li J (2025) DrugLM: a unified framework to enhance drug-target interaction predictions by incorporating textual embeddings via language models. bioRxiv. https:\/\/doi.org\/10.1101\/2025.07.09.657250","journal-title":"bioRxiv"},{"issue":"1","key":"1158_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger D (1988) SMILES, a chemical language and information system 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 28(1):31\u201336. https:\/\/doi.org\/10.1021\/ci00057a005","journal-title":"J Chem Inf Comput Sci"},{"issue":"13","key":"1158_CR27","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","volume":"77","author":"SL Holbeck","year":"2017","unstructured":"Holbeck SL, Camalier R, Crowell JA, Govindharajulu JP, Hollingshead M, Anderson LW, Polley E, Rubinstein L, Srivastava A, Wilsker D, Collins JM, Doroshow JH (2017) The national cancer institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity. Cancer Res 77(13):3564\u20133576. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0489","journal-title":"Cancer Res"},{"issue":"6","key":"1158_CR28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","volume":"15","author":"J O\u2019Neil","year":"2016","unstructured":"O\u2019Neil J, Benita Y, Feldman I, Chenard M, Roberts B, Liu Y, Li J, Kral A, Lejnine S, Loboda A et al (2016) An unbiased oncology compound screen to identify novel combination strategies. Mol Cancer Ther 15(6):1155\u20131162","journal-title":"Mol Cancer Ther"},{"issue":"D1","key":"1158_CR29","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2018","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE (2018) PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 47(D1):1102\u20131109. https:\/\/doi.org\/10.1093\/nar\/gky1033","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1158_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2014","unstructured":"Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, Kok CY, Jia M, De T, Teague JW, Stratton MR, McDermott U, Campbell PJ (2014) COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucleic Acids Res 43(D1):805\u2013811. https:\/\/doi.org\/10.1093\/nar\/gku1075","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"1158_CR31","first-page":"187","volume":"1","author":"B Drewinko","year":"1976","unstructured":"Drewinko B, Loo TL, Brown B, Gottlieb JA, Freireich EJ (1976) Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two drug combinations on cultured human lymphoma cells. Cancer Biochem Biophys 1(4):187\u2013195","journal-title":"Cancer Biochem Biophys"},{"issue":"6","key":"1158_CR32","first-page":"285","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3(6):285\u201390","journal-title":"Arzneimittelforschung"},{"key":"1158_CR33","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2004.09297","author":"K Song","year":"2020","unstructured":"Song K, Tan X, Qin T, Lu J, Liu T-Y (2020) MPNet: masked and permuted pre-training for language understanding. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2004.09297","journal-title":"arXiv"},{"key":"1158_CR34","doi-asserted-by":"crossref","unstructured":"Deka P, Jurek-Loughrey A (2021) Unsupervised keyword combination query generation from online health related content for evidence-based fact checking. In: The 23rd international conference on information integration and web intelligence, pp 267\u2013277","DOI":"10.1145\/3487664.3487701"},{"key":"1158_CR35","doi-asserted-by":"crossref","unstructured":"Gu Y, Tinn R, Cheng H, Lucas M, Usuyama N, Liu X, Naumann T, Gao J, Poon H (2020) Domain-specific language model pretraining for biomedical natural language processing","DOI":"10.1145\/3458754"},{"key":"1158_CR36","doi-asserted-by":"crossref","unstructured":"Yasunaga M, Leskovec J, Liang P (2022) Linkbert: pretraining language models with document links. In: Association for computational linguistics (ACL)","DOI":"10.18653\/v1\/2022.acl-long.551"},{"key":"1158_CR37","doi-asserted-by":"publisher","unstructured":"Bai J, et al (2023) Qwen technical report. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2309.16609","DOI":"10.48550\/arXiv.2309.16609"},{"key":"1158_CR38","doi-asserted-by":"publisher","unstructured":"Landrum G, Tosco P, Kelley B, Rodriguez R, Cosgrove D, Vianello R, sriniker, gedeck, Jones G, NadineSchneider, Kawashima E, Nealschneider D, Dalke A, Swain M, Cole B, Turk S, Savelev A, Vaucher A, W\u00f3jcikowski M, Take I, Scalfani VF, Walker R, Ujihara K, Probst D, godin g, Pahl A, tadhurst-cdd Lehtivarjo J, Berenger F, jasondbiggs (2024) Rdkit\/Rdkit: 2024_03_3 (Q1 2024) Release. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.11396708","DOI":"10.5281\/zenodo.11396708"},{"key":"1158_CR39","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1512.03385","author":"K He","year":"2015","unstructured":"He K, Zhang X, Ren S, Sun J (2015) Deep residual learning for image recognition. arXiv. https:\/\/doi.org\/10.48550\/arXiv.1512.03385","journal-title":"arXiv"},{"key":"1158_CR40","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1606.08415","author":"D Hendrycks","year":"2016","unstructured":"Hendrycks D, Gimpel K (2016) Bridging nonlinearities and stochastic regularizers with gaussian error linear units. arXiv. https:\/\/doi.org\/10.48550\/arXiv.1606.08415","journal-title":"arXiv"},{"key":"1158_CR41","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1607.06450","author":"JL Ba","year":"2016","unstructured":"Ba JL, Kiros JR, Hinton GE (2016) Layer normalization. arXiv. https:\/\/doi.org\/10.48550\/arXiv.1607.06450","journal-title":"arXiv"},{"key":"1158_CR42","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1702.03118","author":"S Elfwing","year":"2017","unstructured":"Elfwing S, Uchibe E, Doya K (2017) Sigmoid-weighted linear units for neural network function approximation in reinforcement learning. arXiv. https:\/\/doi.org\/10.48550\/arXiv.1702.03118","journal-title":"arXiv"},{"key":"1158_CR43","unstructured":"Liu H, Dai Z, So D, Le QV (2021) Pay Attention to MLPs. Inc, Curran Associates"},{"issue":"1","key":"1158_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-024-00839-8","volume":"16","author":"X Zhao","year":"2024","unstructured":"Zhao X, Xu J, Shui Y, Xu M, Hu J, Liu X, Che K, Wang J, Liu Y (2024) Permutedds: a permutable feature fusion network for drug-drug synergy prediction. J Cheminform 16(1):41. https:\/\/doi.org\/10.1186\/s13321-024-00839-8","journal-title":"J Cheminform"},{"issue":"1","key":"1158_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad522","volume":"25","author":"W Wang","year":"2024","unstructured":"Wang W, Yuan G, Wan S, Zheng Z, Liu D, Zhang H, Li J, Zhou Y, Wang X (2024) A granularity-level information fusion strategy on hypergraph transformer for predicting synergistic effects of anticancer drugs. Brief Bioinform 25(1):522. https:\/\/doi.org\/10.1093\/bib\/bbad522","journal-title":"Brief Bioinform"},{"issue":"20","key":"1158_CR46","doi-asserted-by":"publisher","first-page":"4782","DOI":"10.1093\/bioinformatics\/btac579","volume":"38","author":"X Liu","year":"2022","unstructured":"Liu X, Song C, Liu S, Li M, Zhou X, Zhang W (2022) Multi-way relation-enhanced hypergraph representation learning for anti-cancer drug synergy prediction. Bioinformatics 38(20):4782\u20134789. https:\/\/doi.org\/10.1093\/bioinformatics\/btac579","journal-title":"Bioinformatics"},{"issue":"16","key":"1158_CR47","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1093\/bioinformatics\/btaa287","volume":"36","author":"Z Sun","year":"2020","unstructured":"Sun Z, Huang S, Jiang P, Hu P (2020) DTF: deep tensor factorization for predicting anticancer drug synergy. Bioinformatics 36(16):4483\u20134489. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa287","journal-title":"Bioinformatics"},{"key":"1158_CR48","doi-asserted-by":"publisher","unstructured":"Qwen et al (2025) Qwen2.5 technical report. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2412.15115","DOI":"10.48550\/arXiv.2412.15115"},{"key":"1158_CR49","doi-asserted-by":"publisher","unstructured":"OpenAI et al (2024) GPT-4o system card. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2410.21276","DOI":"10.48550\/arXiv.2410.21276"},{"key":"1158_CR50","doi-asserted-by":"publisher","unstructured":"Team G, et al (2024) Gemini 1.5: unlocking multimodal understanding across millions of tokens of context. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2403.05530","DOI":"10.48550\/arXiv.2403.05530"},{"key":"1158_CR51","doi-asserted-by":"publisher","unstructured":"DeepSeek-AI et al (2025) DeepSeek-V3 technical report. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2412.19437","DOI":"10.48550\/arXiv.2412.19437"},{"key":"1158_CR52","doi-asserted-by":"publisher","unstructured":"DeepSeek-AI et al (2025) DeepSeek-R1: incentivizing reasoning capability in LLMs via reinforcement learning. arXiv. https:\/\/doi.org\/10.48550\/arXiv.2501.12948","DOI":"10.48550\/arXiv.2501.12948"},{"key":"1158_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12859-024-05847-x","volume":"25","author":"SS Sadeghi","year":"2024","unstructured":"Sadeghi SS, Bui A, Forooghi A, Lu J, Ngom A (2024) Can large language models understand molecules? BMC Bioinform 25:225","journal-title":"BMC Bioinform"},{"issue":"12","key":"1158_CR54","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1080\/15384047.2015.1095409","volume":"16","author":"L Xu","year":"2015","unstructured":"Xu L, Lei J, Jiang D, Zhou L, Wang S, Fan W (2015) Reversal effects of raloxifene on paclitaxel resistance in 2 MDR breast cancer cells. Cancer Biol Ther 16(12):1794\u20131801. https:\/\/doi.org\/10.1080\/15384047.2015.1095409","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"1158_CR55","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/CAD.0000000000000350","volume":"27","author":"S Wen","year":"2016","unstructured":"Wen S, Fu X, Li G, He L, Zhao C, Hu X, Pan R, Guo C, Zhang X, Hu X (2016) Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy. Anticancer Drugs 27(5):447\u2013456. https:\/\/doi.org\/10.1097\/CAD.0000000000000350","journal-title":"Anticancer Drugs"},{"issue":"1","key":"1158_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1023\/a:1006254315174","volume":"56","author":"Y Kano","year":"1999","unstructured":"Kano Y, Akutsu M, Suzuki K, Ando J, Tsunoda S (1999) Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro. Breast Cancer Res Treat 56(1):79\u201390. https:\/\/doi.org\/10.1023\/a:1006254315174","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1158_CR57","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0959-8049(97)89023-5","volume":"33","author":"A Photiou","year":"1997","unstructured":"Photiou A, Shah P, Leong LK, Moss J, Retsas S (1997) In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines. Eur J Cancer 33(3):463\u2013470. https:\/\/doi.org\/10.1016\/S0959-8049(97)89023-5","journal-title":"Eur J Cancer"},{"key":"1158_CR58","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2255","author":"SD Young","year":"2006","unstructured":"Young SD, Whissell M, Noble J, Cano P, Lopez PG, Germond C (2006) Phase II clinicalTrial results involvingTreatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced SolidTumors. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-2255","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1158_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010200","volume":"19","author":"D Baptista","year":"2023","unstructured":"Baptista D, Ferreira PG, Rocha M (2023) A systematic evaluation of deep learning methods for the prediction of drug synergy in cancer. PLoS Comput Biol 19(3):1010200. https:\/\/doi.org\/10.1371\/journal.pcbi.1010200","journal-title":"PLoS Comput Biol"},{"key":"1158_CR60","doi-asserted-by":"publisher","DOI":"10.1101\/2025.04.18.649584","author":"EB \u00c7and\u0131r","year":"2025","unstructured":"\u00c7and\u0131r EB, Kuru H\u0130, Rattray M, Cicek AE, Tastan O (2025) One-hot news: drug synergy models take a shortcut. bioRxiv. https:\/\/doi.org\/10.1101\/2025.04.18.649584","journal-title":"bioRxiv"},{"key":"1158_CR61","doi-asserted-by":"publisher","unstructured":"hairball-su: hairball-su\/CoSynLLM: the code and datasets for CoSynLLM. https:\/\/doi.org\/10.5281\/zenodo.17446524","DOI":"10.5281\/zenodo.17446524"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13321-026-01158-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-026-01158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-026-01158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:58:54Z","timestamp":1778155134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13321-026-01158-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1158"],"URL":"https:\/\/doi.org\/10.1186\/s13321-026-01158-w","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no Conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}